tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Vertex Pharmaceuticals price target raised to $517 from $515 at JPMorgan
PremiumThe FlyVertex Pharmaceuticals price target raised to $517 from $515 at JPMorgan
8d ago
Vertex Pharmaceuticals presents long-term data on CASGEVY
Premium
The Fly
Vertex Pharmaceuticals presents long-term data on CASGEVY
19d ago
Vertex Pharmaceuticals announces EC approval for Alyftrek for CF treatment
Premium
The Fly
Vertex Pharmaceuticals announces EC approval for Alyftrek for CF treatment
21d ago
Vertex Pharmaceuticals presents new data on ALYFTREK at ECFS Conference
PremiumThe FlyVertex Pharmaceuticals presents new data on ALYFTREK at ECFS Conference
2M ago
BMO Capital Markets Reiterates ‘Buy’ Rating on Eli Lilly Stock (LLY)
Premium
Market News
BMO Capital Markets Reiterates ‘Buy’ Rating on Eli Lilly Stock (LLY)
2M ago
Vertex Pharmaceuticals: Strong Buy Rating Backed by Leadership in NAV1.8 Inhibitors and Strategic Collaborations
Premium
Ratings
Vertex Pharmaceuticals: Strong Buy Rating Backed by Leadership in NAV1.8 Inhibitors and Strategic Collaborations
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100